Matches in DBpedia 2014 for { <http://dbpedia.org/resource/AEZS-108> ?p ?o. }
Showing items 1 to 18 of
18
with 100 items per page.
- AEZS-108 abstract "AEZS-108 (previously AN-152) consists of [D-Lys(6)]LHRH linked to doxorubicin.It is an experimental targeted therapy for various cancers (ovarian, endometrial, breast, bladder, prostate) that express LHRH receptor. The U.S. Food and Drug Administration (FDA) has granted it orphan drug status for ovarian cancer.".
- AEZS-108 wikiPageID "28796495".
- AEZS-108 wikiPageRevisionID "590539911".
- AEZS-108 drugName "AEZS-108".
- AEZS-108 hasPhotoCollection AEZS-108.
- AEZS-108 legalStatus "Investigational".
- AEZS-108 synonyms "AN-152; Zoptarelin doxorubicin".
- AEZS-108 subject Category:Experimental_cancer_drugs.
- AEZS-108 type Drug.
- AEZS-108 type FunctionalSubstance.
- AEZS-108 comment "AEZS-108 (previously AN-152) consists of [D-Lys(6)]LHRH linked to doxorubicin.It is an experimental targeted therapy for various cancers (ovarian, endometrial, breast, bladder, prostate) that express LHRH receptor. The U.S. Food and Drug Administration (FDA) has granted it orphan drug status for ovarian cancer.".
- AEZS-108 label "AEZS-108".
- AEZS-108 sameAs m.0ddcnyf.
- AEZS-108 sameAs Q4651377.
- AEZS-108 sameAs Q4651377.
- AEZS-108 wasDerivedFrom AEZS-108?oldid=590539911.
- AEZS-108 isPrimaryTopicOf AEZS-108.
- AEZS-108 name "AEZS-108".